This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) inched 0.61% higher to $23.22 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 1.45% to 11,358.41 and the Dow Jones Industrial Average rising 0.17% to 33,592.92. Novavax Inc. closed $213.28 below its 52-week high ($236.50), which the company achieved on December 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Replimune Group Inc. (REPL) fell 4.60% to $19.69, VBI Vaccines Inc. (VBIV) rose 10.34% to $0.68, and AnaptysBio Inc. (ANAB) fell 0.86% to $29.96. Trading volume (4.5 M) remained 673,661 below its 50-day average volume of 5.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 15, 2022.
(END) Dow Jones Newswires
November 15, 2022 17:13 ET (22:13 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.